Membranous glomerulonephritis; Membranous GN; Extramembranous glomerulonephritis; Glomerulonephritis - membranous; MGN
Membranous nephropathy is a kidney disorder that leads to changes and inflammation of the structures inside the kidney that help filter wastes and fluids. The inflammation may lead to problems with kidney function.
Membranous nephropathy is caused by the thickening of a part of the glomerular basement membrane. The glomerular basement membrane is a part of the kidneys that helps filter waste and extra fluid from the blood. The exact reason for this thickening is not known.
The thickened glomerular membrane does not work normally. As a result, large amounts of protein are lost in the urine.
This condition is one of the most common causes of nephrotic syndrome. This is a group of symptoms that include protein in the urine, low blood protein level, high cholesterol levels, high triglyceride levels, and swelling. Membranous nephropathy may be a primary kidney disease, or it may be associated with other conditions.
The following increase your risk for this condition:
- Cancers, especially lung and colon cancer
- Exposure to toxins, including gold and mercury
- Infections, including hepatitis B, malaria, syphilis, and endocarditis
- Medicines, including penicillamine, trimethadione, and skin-lightening creams
- Systemic lupus erythematosus, rheumatoid arthritis, Graves disease, and other autoimmune disorders
The disorder occurs at any age, but is more common after age 40.
Symptoms often begin slowly over time, and may include:
Exams and Tests
A physical exam may show swelling (edema).
A urinalysis may reveal a large amount of protein in the urine. There may also be some blood in the urine. The glomerular filtration rate (the "speed" at which the kidneys cleanse the blood) is often nearly normal.
Other tests may be done to see how well the kidneys are working and how the body is adapting to the kidney problem. These include:
A kidney biopsy confirms the diagnosis.
The following tests can help determine the cause of membranous nephropathy:
- Antinuclear antibodies test
- Anti-double-strand DNA, if the antinuclear antibodies test is positive
- Blood tests to check for hepatitis B, hepatitis C, and syphilis
- Complement levels
- Cryoglobulin test
The goal of treatment is to reduce symptoms and slow the progression of the disease.
Controlling blood pressure is the most important way to delay kidney damage. The goal is to keep blood pressure at or below 130/80 mm Hg. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are the medicines most often used to lower blood pressure.
Corticosteroids and other drugs that suppress the immune system may be used.
High blood cholesterol and triglyceride levels should be treated to reduce the risk of atherosclerosis. However, a low-fat, low-cholesterol diet is often not as helpful for people with membranous nephropathy. Medicines to reduce cholesterol and triglyceride levels (most often statins) may be recommended.
A low-salt diet may help with swelling in the hands and legs. Water pills (diuretics) may also help with this problem.
Low-protein diets may be helpful. A moderate-protein diet (1 gram [gm] of protein per kilogram [kg] of body weight per day) may be suggested.
Vitamin D may need to be replaced if nephrotic syndrome is long-term (chronic) and does not respond to therapy.
This disease increases the risk for blood clots in the lungs and legs. Blood thinners may be prescribed to prevent these complications.
The outlook varies, depending on the amount of protein loss. There may be symptom-free periods and occasional flare-ups. Sometimes, the condition goes away, with or without therapy.
Most people with this disease will have kidney damage and some people will develop end-stage renal disease.
Complications that may result from this disease include:
When to Contact a Medical Professional
Call for an appointment with your health care provider if:
Quickly treating disorders and avoiding substances that can cause membranous nephropathy may reduce your risk.
Manoharon A, Schelling JR, Diamond M, Chung-Park M, Madaio M, Sedor JR. Immune and inflammatory glomerular diseases. In: Alpern RJ, Moe OW, Caplan MJ, eds. Seldin and Giebisch's The Kidney. 5th ed. Philadelphia, PA: Elsevier; 2013:chap 82.
Salant DJ, Cattran DC. Membranous nephropathy. In: Johnson RJ, Feehally J, Floege J, eds. Comprehensive Clinical Nephrology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2015:chap 20.